Michel Van Houdt

Michel Van Houdt

Auto-generated profile, based on publicly available information

Michel Van Houdt

Immunology–Allergology–Rheumatology, Faculty of Medicine and Health Sciences Antwerp University, Hospital, Infla‐Med Centre of Excellence, Antwerp University, University of Antwerp Antwerp Belgium

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AGAnnemarie van de Geer
Annemarie van de Geer
ANAlejandro Nieto-Patlán
Alejandro Nieto-Patlán
DKDouglas B. Kuhns
Douglas B. Kuhns
ATAnton T.J. Tool
Anton T.J. Tool
AAAndrés A. Arias
Andrés A. Arias
JBJacinta Bustamante
Jacinta Bustamante
Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40phox subunit of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 p40phox-deficient patients from 12 additional families in 8 countries. These patients display 8 different in-frame or out-of-frame mutations of NCF4 that are homozygous in 11 of the families and compound heterozygous in another. When overexpressed in NB4 neutrophil-like cells and EBV-transformed B cells in vitro, the mutant alleles were found to be LOF, with the exception of the p.R58C and c.120_134del alleles, which were hypomorphic. Particle-induced NADPH oxidase activity was severely impaired in the patients’ neutrophils, whereas PMA-induced dihydrorhodamine-1,2,3 (DHR) oxidation, which is widely used as a diagnostic test for chronic granulomatous disease (CGD), was normal or mildly impaired in the patients. Moreover, the NADPH oxidase activity of EBV-transformed B cells was also severely impaired, whereas that of mononuclear phagocytes was normal. Finally, the killing of Candida albicans and Aspergillus fumigatus hyphae by neutrophils was conserved in these patients, unlike in patients with CGD. The patients suffer from hyperinflammation and peripheral infections, but they do not have any of the invasive bacterial or fungal infections seen in CGD. Inherited p40phox deficiency underlies a distinctive condition, resembling a mild, atypical form of CGD.

7 July 2021 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
JEJessy Elst
Jessy Elst
MPMarie‐Line M. van der Poorten
Marie‐Line M. van der Poorten
AGAthina L. Van Gasse
Athina L. Van Gasse
LPLeander De Puysseleyr
Leander De Puysseleyr
MHMargo M. Hagendorens
Margo M. Hagendorens
DEDidier G. Ebo
Didier G. Ebo

11 June 2020 in Blood
Verified
Journal Article
Closed access
PDF file
ESEvelien G.G. Sprenkeler
Evelien G.G. Sprenkeler
SHStefanie S. V. Henriet
Stefanie S. V. Henriet
ATAnton T. J. Tool
Anton T. J. Tool
IKIris C. Kreft
Iris C. Kreft
IBIvo van der Bijl
Ivo van der Bijl
TKTaco W. Kuijpers
Taco W. Kuijpers
Megakaryoblastic leukemia 1 (MKL1) promotes the regulation of essential cell processes, including actin cytoskeletal dynamics by co-activating serum response factor. Recently, the first human case with MKL1 deficiency, leading to a novel primary immunodeficiency, was identified. We report a second family with two siblings with a homozygous frameshift mutation in MKL1. The index case deceased as an infant from progressive and severe pneumonia by Pseudomonas aeruginosa and poor wound healing. The younger sib was preemptively transplanted shortly after birth. The immunodeficiency was marked by a pronounced actin polymerization defect and a strongly reduced motility and chemotactic response by MKL1-deficient neutrophils. Apart from the lack of MKL1, subsequent proteomic and transcriptomic analyses of patient neutrophils revealed actin and several actin-related proteins to be downregulated, confirming a role for MKL1 as transcriptional co-regulator. Degranulation was enhanced upon suboptimal neutrophil activation, while production of reactive oxygen species was normal. Neutrophil adhesion was intact but without proper spreading. The latter could explain the observed failure in firm adherence and transendothelial migration under flow conditions. No apparent defect in phagocytosis and bacterial killing was found. Also monocyte-derived macrophages showed intact phagocytosis; lymphocyte counts and proliferative capacity were normal. Non-hematopoietic primary patient fibroblasts demonstrated defective differentiation into myofibroblasts but normal migration and filamentous actin (F-actin) content, most probably due to compensatory mechanisms of MKL2, which is not expressed in neutrophils. Our findings extend current insight into the severe immune dysfunction in MKL1 deficiency, with cytoskeletal dysfunction and defective extravasation of neutrophils as most prominent features.

31 March 2022 in Blood Advances
Verified
Journal Article
Open access
PDF file
DRDieke J. van Rees
Dieke J. van Rees
MBMaximilian Brinkhaus
Maximilian Brinkhaus
BKBart Klein
Bart Klein
PVPaul Verkuijlen
Paul Verkuijlen
ATAnton T.J. Tool
Anton T.J. Tool
Timo K. van den BergTimo K. van den Berg
Timo K. van den Berg
Anti-CD20 antibodies such as rituximab are broadly used to treat B-cell malignancies. These antibodies can induce various effector functions, including immune cell-mediated antibody-dependent cellular cytotoxicity (ADCC). Neutrophils can induce ADCC toward solid cancer cells by trogoptosis, a cytotoxic mechanism known to be dependent on trogocytosis. However, neutrophils seem to be incapable of killing rituximab-opsonized B-cell lymphoma cells. Nevertheless, neutrophils do trogocytose rituximab-opsonized B-cell lymphoma cells, but this only reduces CD20 surface expression and is thought to render tumor cells therapeutically resistant to further rituximab-dependent destruction. Here, we demonstrate that resistance of B-cell lymphoma cells toward neutrophil killing can be overcome by a combination of CD47-SIRPα checkpoint blockade and sodium stibogluconate (SSG), an anti-leishmaniasis drug and documented inhibitor of the tyrosine phosphatase SHP-1. SSG enhanced neutrophil-mediated ADCC of solid tumor cells but enabled trogoptotic killing of B-cell lymphoma cells by turning trogocytosis from a mechanism that contributes to resistance into a cytotoxic anti-cancer mechanism. Tumor cell killing in the presence of SSG required both antibody opsonization of the target cells and disruption of CD47-SIRPα interactions. These results provide a more detailed understanding of the role of neutrophil trogocytosis in antibody-mediated destruction of B cells and clues on how to further optimize antibody therapy of B-cell malignancies.

1 January 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
DEDidier G. Ebo
Didier G. Ebo
MBMichiel Beyens
Michiel Beyens
KHKevin Heremans
Kevin Heremans
MPMarie-Line M. van der Poorten
Marie-Line M. van der Poorten
AGAthina L. Van Gasse
Athina L. Van Gasse
JEJessy Elst
Jessy Elst
Immediate hypersensitivity reactions can pose a clinical and diagnostic challenge, mainly because of the multifarious clinical presentation and distinct underlying – frequently uncertain – mechanisms. Anaphylaxis encompasses all rapidly developing and life-threatening signs and may cause death. Evidence has accumulated that immediate hypersensitivity and anaphylaxis do not necessarily involve an allergen-specific immune response with cross-linking of specific IgE (sIgE) antibodies bound to their high-affinity IgE receptor (FcεRI) on the surface of mast cells (MCs) and basophils. Immediate hypersensitive and anaphylaxis can also result from alternative specific and nonspecific MC and basophils activation and degranulation, such as complementderived anaphylatoxins and off-target occupancy of MC and/or basophil surface receptors such as the Masrelated G protein-coupled receptor X2 (MRGPRX2). Degranulation of MCs and basophils results in the release of inflammatory mediators, which can be, depending on the underlying trigger, in a different spatiotemporal manner. In addition, hypersensitivity and anaphylaxis can occur entirely independently of MC and basophil degranulation, as observed in hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) that divert normal arachidonic acid metabolism by inhibiting the cyclooxygenase (COX)-1 isoenzyme. Finally, one should remember that anaphylaxis might be part of the phenotype of particular - sometimes poorly recognizable - conditions such as clonal MC diseases (e.g. mastocytosis) and MC activation syndrome (MCAS). This review provides a status update on the molecular mechanisms involved in both sIgE/FcεRI- and non-sIgE/FcεRIdependent immediate hypersensitivity and anaphylaxis. In conclusion, there is increasing evidence for alternative pathophysiological hypersensitivity and anaphylaxis endotypes that are phenotypically and biologically indistinguishable, which are frequently difficult to diagnose, mainly because of uncertainties associated with diagnostic tests that might not enable to unveil the underlying mechanism.

3 February 2020 in Cytometry Part B: Clinical Cytometry
Verified
Journal Article
Closed access
PDF file
DEDidier G. Ebo
Didier G. Ebo
JEJessy Elst
Jessy Elst
MHMichel van Houdt
Michel van Houdt
IPIsabel Pintelon
Isabel Pintelon
JTJean‐Pierre Timmermans
Jean‐Pierre Timmermans
VSVito Sabato
Vito Sabato